期刊文献+

易善复联合复方丹参治疗肝炎肝纤维化临床研究 被引量:14

Effect of essential plus red saqe root on virus hepatitis complicated with hepatic fibrosis
暂未订购
导出
摘要 目的评价易善复联合复方丹参治疗肝炎肝纤维化的临床疗效。方法选择病毒性乙型肝炎合并肝纤维化患者72例,随机分成治疗组和对照组,治疗组40例,应用易善复加复方丹参治疗,疗程2个月。结果治疗组肝功能丙氨酸转氨酶(ALT)、胆红素,肝纤维化指标及临床症状等项目的改善均明显优于对照组(P<0.01或0.05),且无明显副作用。结论易善复加复方丹参治疗病毒性肝炎合并肝纤维化对促进肝脏脂肪代谢、降低血脂、修复损伤的肝细胞,且阻止或改善肝纤维化均有明显的功效。 Objective To evaluate the therapeutic effect of essential and red saqe root on virus hepatitis merging hepatic fibrosis. Methods Seventy -two patients with virus hepatitis merging fibrosis were divided into treatment group and control group randomly. There were 40 csaes in the treatment group and the therapy lasted 2 months. Results ALT, TBIL, the index of hepatic fibrosis and clinical symptoms in treatment group were obviously improved. There were significant differences between the two groups ( P 〈 0.05 or P 〈 0.01 ), and there was no obviously vice - reaction. Conclusion Essentials and red saqe root can promote the grease~ metabolism of liver, repair the damage of hepatic cell and prevent the progress of hepatic fibrosis.
出处 《中原医刊》 2006年第8期14-15,共2页 Central Plains Medical Journal
关键词 病毒性肝炎 肝纤维化 易善复 丹参 Virus hepatitis Hepatic fibrosis Essential Red saqe root
  • 相关文献

参考文献6

二级参考文献32

  • 1叶红军,高永生,王丽英,肖红,计秀生,潘春芝,冯雪梅.血清Ⅲ型前胶原对肝纤维化的诊断价值[J].临床肝胆病杂志,1993,9(2):90-92. 被引量:65
  • 2Wu J, Zern MA. Hepatic stellate cells: a target treatment of liver fibrosis, Gastroenterol.2000, 35 (9): 666-672.
  • 3Schuppan D, Strobel D, Hahn EG.Hepatic fibrosis - therapeutic strategies.Digestion, 1998, 59:385-390.
  • 4Qi Z, Atsushi N, Doshima A, et al. Blockade of type beta transtomaing growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci USA, 1999, 96 (5): 2345- 2349.
  • 5Inagaki Y, Mamura M, Kanarnaru Y, et al. Constitutive phosphorylation mad nuclear localization of Smad3 are correlated with incread collagen gene transcription in activated hepatic stellate cells.Cell Phys;ol2001, 187 (1): 117-123.
  • 6Dooley S, Delvoux B, Lahme B, et al. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology, 2000, 31 (5) :1094- 1106.
  • 7Stopa M, Benes V, Ansorge W, et al. Gentle locus and promoter region of rat Smad7, an important antagonist of TGF beta signaling. Mamm Genome, 2000, 11 : 169-176.
  • 8Raftery LA, Twombly V, Wharton K, et al. Genetic screens to identity elements of the decapentaplegic signaling pathway in Drosophila.Genetics, 1995, 139 (1): 241-254.
  • 9Sekelsky J J, Newfeld SJ, Raftery LA, et od. Genetic characterization and cloning of mothers agaist dpp, a gene required for decapentaplegic function in Drosophila melanogaster.Geneties, 1995, 139 (3): 1347- 1358.
  • 10Schnabl B, Kweon Yo, Frederick JP, et al. The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology, 2001, (1): 89-100.

共引文献574

同被引文献73

引证文献14

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部